Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiki Okuyama

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Hematology|September 5, 2003
Use of octreotide in the management of severe duodenal bleeding after unrelated-donor bone marrow transplantationKazuteru Ohashi, Masaki Sanaka, Yuji Tanaka, et al.
Pathology Oncology Research : POR|June 17, 2008
Delayed hematological recovery following autologous transplantation utilizing peripheral blood stem cells harvested after treatment with arsenic trioxideToshimitsu Ueki, Kazuteru Ohashi, Minako Jinta, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 24, 2003
[Sustained remission of MDS overt leukemia associated with abrupt discontinuation of immunosuppression following relapse after the second course of allogeneic hematopoietic stem cell transplantation]Kazuteru Ohashi, Michiaki Mikoshiba, Yuji Tanaka, et al.
International Journal of Hematology|February 6, 2003
Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host diseaseKazuteru Ohashi, Yuji Tanaka, Shin-ichiro Mori, et al.
International Journal of Hematology|August 18, 2005
Granulocyte colony-stimulating factor-primed donor lymphocyte infusion after salvage chemotherapy for treatment of relapsed acute leukemia after allogeneic stem cell transplantationTakeshi Kobayashi, Kazuteru Ohashi, Miwa Sakai, et al.
Transfusion|June 23, 2015
Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactionsHidefumi Kato, Takayuki Nakayama, Motoaki Uruma, et al.
American Journal of Clinical Pathology|July 31, 2013
Incidence of transfusion-related adverse reactions per patient reflects the potential risk of transfusion therapy in JapanHidefumi Kato, Motoaki Uruma, Yoshiki Okuyama, et al.
International Journal of Hematology|February 15, 2002
Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemiaMichiaki Mikoshiba, Kazuteru Ohashi, Naoko Takei, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 21, 2016
Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating FactorKeita Yamamoto, Noriko Doki, Yasushi Senoo, et al.
Cancer Science|March 28, 2020
Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34<sup>+</sup> cells under cytokine stimulationYuka Harada, Naoki Shingai, Ye Ding, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Hematology|September 5, 2003
Use of octreotide in the management of severe duodenal bleeding after unrelated-donor bone marrow transplantationKazuteru Ohashi, Masaki Sanaka, Yuji Tanaka, et al.
Pathology Oncology Research : POR|June 17, 2008
Delayed hematological recovery following autologous transplantation utilizing peripheral blood stem cells harvested after treatment with arsenic trioxideToshimitsu Ueki, Kazuteru Ohashi, Minako Jinta, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 24, 2003
[Sustained remission of MDS overt leukemia associated with abrupt discontinuation of immunosuppression following relapse after the second course of allogeneic hematopoietic stem cell transplantation]Kazuteru Ohashi, Michiaki Mikoshiba, Yuji Tanaka, et al.
International Journal of Hematology|February 6, 2003
Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host diseaseKazuteru Ohashi, Yuji Tanaka, Shin-ichiro Mori, et al.
International Journal of Hematology|August 18, 2005
Granulocyte colony-stimulating factor-primed donor lymphocyte infusion after salvage chemotherapy for treatment of relapsed acute leukemia after allogeneic stem cell transplantationTakeshi Kobayashi, Kazuteru Ohashi, Miwa Sakai, et al.
Transfusion|June 23, 2015
Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactionsHidefumi Kato, Takayuki Nakayama, Motoaki Uruma, et al.
American Journal of Clinical Pathology|July 31, 2013
Incidence of transfusion-related adverse reactions per patient reflects the potential risk of transfusion therapy in JapanHidefumi Kato, Motoaki Uruma, Yoshiki Okuyama, et al.
International Journal of Hematology|February 15, 2002
Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemiaMichiaki Mikoshiba, Kazuteru Ohashi, Naoko Takei, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 21, 2016
Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating FactorKeita Yamamoto, Noriko Doki, Yasushi Senoo, et al.
Cancer Science|March 28, 2020
Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34<sup>+</sup> cells under cytokine stimulationYuka Harada, Naoki Shingai, Ye Ding, et al.
Pageof 6